| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.87B | 44.28B | 38.96B | 35.82B | 44.20B | 33.57B |
| Gross Profit | 24.72B | 24.55B | 21.90B | 19.95B | 25.57B | 19.30B |
| EBITDA | 13.73B | 14.93B | 12.74B | 9.95B | 17.25B | 11.37B |
| Net Income | 5.37B | 5.54B | 10.14B | 7.23B | 12.94B | 9.04B |
Balance Sheet | ||||||
| Total Assets | 53.03B | 50.14B | 55.15B | 51.04B | 49.01B | 41.24B |
| Cash, Cash Equivalents and Short-Term Investments | 11.82B | 12.48B | 13.30B | 11.32B | 6.38B | 12.41B |
| Total Debt | 14.82B | 16.37B | 15.44B | 16.07B | 16.16B | 16.30B |
| Total Liabilities | 29.96B | 28.94B | 28.88B | 29.46B | 31.00B | 31.29B |
| Stockholders Equity | 23.07B | 21.21B | 26.27B | 21.58B | 18.01B | 9.95B |
Cash Flow | ||||||
| Free Cash Flow | 12.93B | 12.82B | 11.16B | 9.85B | 6.83B | 8.65B |
| Operating Cash Flow | 14.39B | 14.01B | 12.20B | 11.30B | 9.10B | 10.54B |
| Investing Cash Flow | -1.85B | -800.00M | -3.62B | 762.00M | -5.80B | -3.36B |
| Financing Cash Flow | -14.07B | -13.20B | -9.27B | -6.66B | -7.20B | -6.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $155.41B | 45.73 | 7.92% | 1.43% | 16.89% | 39.29% | |
71 Outperform | $354.61B | 80.54 | 7.18% | ― | 34.34% | 163.27% | |
70 Outperform | $135.30B | 15.44 | 21.63% | 2.01% | 10.25% | -48.23% | |
70 Outperform | $177.42B | 31.53 | 30.44% | 3.11% | 9.90% | 1.65% | |
63 Neutral | $49.16B | 27.14 | 20.73% | 1.79% | -6.81% | -23.16% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | $251.65B | -658.38 | -0.26% | ― | -0.47% | 98.20% |